Literature DB >> 34325748

Should prophylaxis of venous thromboembolism in Asian patients undergoing knee and hip arthroplasty and hip fracture surgery be an issue?

Aree Tanavalee1.   

Abstract

Entities:  

Year:  2021        PMID: 34325748      PMCID: PMC8323214          DOI: 10.1186/s43019-021-00105-3

Source DB:  PubMed          Journal:  Knee Surg Relat Res        ISSN: 2234-0726


× No keyword cloud information.
Postoperative venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients undergoing knee and hip arthroplasty and hip fracture surgery, while VTE is considered potentially preventable with several modalities of prophylactic management [1]. The VTE prevention guidelines by the American Academy of Orthopedic Surgeons (AAOS) or the American College of Chest Physicians (AACP) have been implemented in most countries in Asia [2, 3]. However, there are some concerning issues and complications related to VTE prophylaxis in major joint replacement and hip fracture surgeries according to these guidelines, due to differences in the healthcare systems and various cultural aspects [4-6]. Among orthopedic surgeons who practice in the Asia-Pacific (AP) region, some alternative options for VTE prevention in hip and knee arthroplasty and hip fracture surgery are believed to be necessary [7-10]. These Asian-specific guideline/consensus statements are expected to provide better patient outcomes and compliance. Therefore, in a 1-year period, The Thai Hip and Knee Society (THKS) has initiated an AP consensus agreement on VTE prophylaxis in knee and hip arthroplasty and hip fracture surgery in Asian patients. Ninety-three orthopedic experts from the AP region volunteered to join the consensus using an overall five-round modified Delphi method. According to the results of these AP consensus statements, one should be aware that some agreed methods of VTE prophylaxis are different from those published in international guidelines regarding diagnosis and risk factors and methods of prophylaxis in details. We hope that this AP VTE consensus will provide orthopedic surgeons who practice in the AP region appropriate options for VTE diagnosis and prevention methods that benefit their patients, with fewer complications.
  10 in total

Review 1.  Venous thromboembolism prophylaxis after total joint arthroplasty.

Authors:  Michael A Flierl; Michael J Messina; Justin J Mitchell; Craig Hogan; Robert D'Ambrosia
Journal:  Orthopedics       Date:  2015-04       Impact factor: 1.390

Review 2.  Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics.

Authors:  J Edelsberg; D Ollendorf; G Oster
Journal:  Am J Health Syst Pharm       Date:  2001-11-01       Impact factor: 2.637

3.  The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.

Authors:  Mohamed Yassin; Chris Mitchell; Mohammed Diab; Colin Senior
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

4.  Incidence of clinically significant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulation.

Authors:  Hamid Rahmatullah Bin Abd Razak; Ang Teng Soon; Ian Dominic Dhanaraj; Andrew Hwee Chye Tan
Journal:  J Arthroplasty       Date:  2011-11-15       Impact factor: 4.757

5.  Prevalence and risk factors of thromboembolism after joint arthroplasty without chemical thromboprophylaxis in an Asian population.

Authors:  Man-Hee Won; Gye-Wang Lee; Tong-Joo Lee; Kyoung-Ho Moon
Journal:  J Arthroplasty       Date:  2011-01-21       Impact factor: 4.757

6.  Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population?

Authors:  Kye-Youl Cho; Kang-Il Kim; Sumit Khurana; Dae-Kyung Bae; Wook Jin
Journal:  Arch Orthop Trauma Surg       Date:  2013-02-05       Impact factor: 3.067

Review 7.  Current guidelines for total joint VTE prophylaxis: dawn of a new day.

Authors:  R L Barrack
Journal:  J Bone Joint Surg Br       Date:  2012-11

8.  Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.

Authors:  Gulraj S Matharu; Cesar Garriga; Michael R Whitehouse; Amar Rangan; Andrew Judge
Journal:  J Arthroplasty       Date:  2020-05-06       Impact factor: 4.757

9.  Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?

Authors:  Abiram Bala; Marlon J Murasko; David R Burk; James I Huddleston; Stuart B Goodman; William J Maloney; Derek F Amanatullah
Journal:  Hip Int       Date:  2019-04-16       Impact factor: 2.135

10.  Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography.

Authors:  Seung-Ick Cha; Shin-Yeop Lee; Chang-Ho Kim; Jae-Yong Park; Tae-Hoon Jung; Jae-Hyuck Yi; Jongmin Lee; Seung Huh; Hyun-Joo Lee; Shin-Yoon Kim
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

  10 in total
  1 in total

1.  Association between General Anesthesia and the Occurrence of Cerebrovascular Accidents in Hip Fracture Patients.

Authors:  Hu Wang; Lingyan Gao
Journal:  J Healthc Eng       Date:  2021-12-18       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.